Mariona Calvo

762 total citations
20 papers, 344 citations indexed

About

Mariona Calvo is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Mariona Calvo has authored 20 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 11 papers in Oncology and 4 papers in Surgery. Recurrent topics in Mariona Calvo's work include Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Mariona Calvo is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Mariona Calvo collaborates with scholars based in Spain, United States and Italy. Mariona Calvo's co-authors include Carlota Gudiol, Jordi Carratalà, Carmen Ardanuy, Carolina García‐Vidal, Mar Marín, Montserrat Arnán, Maite G. Fernández‐Barrena, Isabel Fabregat, Pablo Sarobe and Matías A. Ávila and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Journal of Hepatology.

In The Last Decade

Mariona Calvo

16 papers receiving 343 citations

Peers

Countries citing papers authored by Mariona Calvo

Since Specialization

Citations

This map shows the geographic impact of Mariona Calvo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mariona Calvo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mariona Calvo more than expected).

Fields of papers citing papers by Mariona Calvo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mariona Calvo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mariona Calvo. The network helps show where Mariona Calvo may publish in the future.

Co-authorship network of co-authors of Mariona Calvo

This figure shows the co-authorship network connecting the top 25 collaborators of Mariona Calvo. A scholar is included among the top collaborators of Mariona Calvo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mariona Calvo. Mariona Calvo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Mevrometostat (PF-06821497), an enhancer of zeste homolog 2 (EZH2) inhibitor, in combination with enzalutamide in patients with metastatic castration-resistant prostate cancer (mCRPC): A randomized dose-expansion study. 2025 ·Journal of Clinical Oncology ·Michael T. Schweizer, Mariona Calvo, Víctor Moreno, Begoña Mellado, Daniel Castellano, Alexander I. Spira, Qiang Wei, Joan Carles, (unknown), Cheol Kwak, Iwona Ługowska, Konstantin Penkov, Neal D. Shore, Li Liu, Rajendar K. Mittapalli, (unknown), Claudia Andreu‐Vieyra, Neelesh Soman, Teresa Alonso Gordoa	0
2	SEOM-GEMCAD-TTD clinical guidelines for the management of hepatocarcinoma patients (2023) 2024 ·Clinical & Translational Oncology ·Carlos López, Mariona Calvo, Juan Carlos Cámara, Beatriz García-Paredes, Carlos Gómez-Martín, (unknown), Roberto Pazo-Cid, Javier Sastre, Ricardo Yayá, Jaime Feliú	2
3	Efficacy and safety of maintenance therapy with pamiparib versus placebo for advanced gastric cancer responding to first‐line platinum‐based chemotherapy: Phase 2 study results 2023 ·Cancer Medicine ·Fortunato Ciardiello, Yung‐Jue Bang, Andrés Cervantes, Mikhail Dvorkin, Charles D. Lopez, Jean‐Philippe Metges, (unknown), Mariona Calvo, Andrew Strickland, George Kannourakis, Kei Muro, Hisato Kawakami, Wei Jia, Christophe Borg, (unknown), (unknown), Robert J. Pelham, Lin Shen	6
4	Successful closure of a refractory gastrobronchial fistula using endoscopic mucosal ablation followed by single loop-and-clips technique 2023 ·Endoscopy ·Sandra Maisterra, (unknown), (unknown), Mariona Calvo, Leandre Farràn, N. Virgili, Joan B. Gornals	0
5	Dissecting the role of the NADPH oxidase NOX4 in TGF-beta signaling in hepatocellular carcinoma 2023 ·Redox Biology ·(unknown), (unknown), (unknown), Ania Alay, Gabriel Pons, (unknown), (unknown), (unknown), (unknown), Francesco Dituri, Grazia Serino, Emilio Ramos, Teresa Serrano, Mariona Calvo, Maria Luz Martínez‐Chantar, Gianluigi Giannelli, Esther Bertrán, Isabel Fabregat	6
6	A multi-center, open-label, randomized dose expansion study of PF-06821497, a potent and selective inhibitor of enhancer of zeste homolog 2 (EZH2), in patients with metastatic castration-resistant prostate cancer (mCRPC). 2023 ·Journal of Clinical Oncology ·Mariona Calvo, Konstantin Penkov, Alexander I. Spira, (unknown), Neal D. Shore, Tian Zhang, (unknown), Teresa Alonso Gordoa, Luis Paz-Ares Rodríguez, Stefano Tarantolo, J.J. Soto Castillo, Robert Alter, Claudia Andreu‐Vieyra, (unknown), (unknown), Hariharan Subramanian, Michael T. Schweizer	3
7	Interim analysis of the ACTION trial: Cabozantinib for hepatocellular carcinoma patients who discontinued first line treatment other than sorafenib or due to sorafenib intolerance 2023 ·Journal of Hepatology ·(unknown), (unknown), Mariona Calvo, Marı́a Varela, Neus Llarch, (unknown), (unknown), Andrés Castaño‐García, José Luis Lledó, Christie Perelló, (unknown), Ezequiel Mauro, Ángeles García‐Criado, Carmen Ayuso, (unknown), Jordi Rimola, Jordi Bruix, María Reig	0
8	Clinical outcomes in phase 1 clinical trials (Ph1-CT) when treating patients (pts) with novel immunotherapy (IT) agents at early lines for advanced disease. 2023 ·Journal of Clinical Oncology ·J.J. Soto Castillo, (unknown), Agostina Stradella, Rafael Villanueva-Vázquez, Mariona Calvo, Maria Jové, J.C. Ruffinelli, (unknown), Ramón Salazar, Miguel Gil‐Gil, Marta Gil-Martín, Marc Oliva, (unknown)	1
9	Survival and adverse events of elderly patients treated with sorafenib for hepatocellular carcinoma 2022 ·Frontiers in Oncology ·Anna Sòria, Mariona Calvo, Meritxell Casas, (unknown), Sergio Muñoz, Víctor Sapena, Marc Puigvehí, (unknown), (unknown), Adolfo Gallego, Beatriz Mínguez, Diana Horta, (unknown), Silvia Montoliu, Mercè Roget, María Reig, Mercedes Vergara	0
10	Myasthenia Gravis Induced by Immune Checkpoint Inhibitors: An Emerging Neurotoxicity in Neuro-Oncology Practice: Case Series 2022 ·Journal of Clinical Medicine ·Carla Marco, Marta Simó, (unknown), Carlos Casasnovas, Raúl Domínguez, Noelia Vilariño, Mariona Calvo, Juan Martín-Liberal, (unknown), Joan Sabater‐Riera, Jordi Bruna, Roser Velasco	17
11	The TGF-β Pathway: A Pharmacological Target in Hepatocellular Carcinoma? 2021 ·Cancers ·Ester Gonzalez‐Sanchez, Javier Vaquero, Maite G. Fernández‐Barrena, Juan José Lasarte, Matías A. Ávila, Pablo Sarobe, María Reig, Mariona Calvo, Isabel Fabregat	71
12	PARALLEL 303: Phase 2 randomized study of pamiparib vs placebo as maintenance therapy in patients (pts) with inoperable locally advanced or metastatic gastric cancer that responded to platinum-based first-line (1L) chemotherapy. 2021 ·Journal of Clinical Oncology ·Fortunato Ciardiello, Yung‐Jue Bang, Johanna C. Bendell, Andrés Cervantes, Mikhail Dvorkin, Charles D. Lopez, Jean‐Philippe Metges, (unknown), Mariona Calvo, Andrew Strickland, George Kannourakis, Kei Muro, Hisato Kawakami, Jia Wei, Christophe Borg, Song Mu, Kathy Zhang, (unknown), Lin Shen	1
13	MONEO: A phase II study of avelumab (Av) plus FLOT in the peri-operative treatment for patients (pts) with resectable gastric or gastroesophageal junction cancer (GC). 2021 ·Journal of Clinical Oncology ·María Alsina, Mariano Ponz‐Sarvisé, (unknown), Marta González, Carlos E. de Andrea, Alena Gros, Ana Vivancos, Paula Jiménez‐Fonseca, M. Díez García, Virginia Arrazubi, Enrique Sanz‐García, Eva Martínez de Castro, (unknown), Mariona Calvo, Cristina Bugés, Federico Longo, Josep Tabernero, Guillermo Villacampa, Susana Muñoz, Ignacio Melero	3
14	Duloxetine against symptomatic chemotherapy-induced peripheral neurotoxicity in cancer survivors: a real world, open-label experience 2020 ·Anti-Cancer Drugs ·Roser Velasco, (unknown), Andreas A. Argyriou, Cristina Santos, (unknown), Cristina Izquierdo, Marta Simó, Miguel Gil‐Gil, Beatriz Pardo, Laura Jiménez, (unknown), Mariona Calvo, Ramón Palmero, Jordi Bruna	16
15	Endoscopic biliary drainage in unresectable biliary obstruction: the role of endoscopic ultrasound-guidance in a cohort study 2019 ·Revista Española de Enfermedades Digestivas ·(unknown), (unknown), (unknown), (unknown), (unknown), Juli Busquets, Berta Laquente, Mariona Calvo, Joan Fabregat, José Castellote, Joan B. Gornals	4
16	A fresh look at polymicrobial bloodstream infection in cancer patients 2017 ·PLoS ONE ·Cristina Royo, Carlota Gudiol, Carmen Ardanuy, Helena Pomares, Mariona Calvo, Jordi Carratalà	43
17	Clinical relevance of histologic subtypes in locally advanced esophageal carcinoma treated with pre-operative chemoradiotherapy: Experience of a monographic oncologic centre 2017 ·PLoS ONE ·Maria Saigí, Marc Oliva, Luisa Aliste, Mariona Calvo, (unknown), (unknown), (unknown), Leandre Farràn, (unknown), (unknown), María José Paúles, Joan B. Gornals, Eugenia De Lama, Josep M. Borràs, Núria Sala, Maica Galán	6
18	Bloodstream infections in neutropenic patients with cancer: Differences between patients with haematological malignancies and solid tumours 2014 ·Journal of Infection ·Mar Marín, Carlota Gudiol, Carmen Ardanuy, Carolina García‐Vidal, Mariona Calvo, Montserrat Arnán, Jordi Carratalà	92
19	Treatment of complete esophageal stenosis using endoscopic ultrasound-guided puncture: a novel technique for access to the distal lumen 2014 ·Endoscopy ·Joan B. Gornals, (unknown), Josep Castellví, Xavier Ariza, Mariona Calvo, Maica Galán	9
20	Epidemiology, antibiotic therapy and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in cancer patients 2013 ·Supportive Care in Cancer ·Marta Bodro, Carlota Gudiol, Carolina García‐Vidal, Fé Tubau, (unknown), Lucía Boix-Palop, Eva Domingo‐Doménech, Mariona Calvo, Jordi Carratalà	64

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact